ARUNA BIO INC.

In News

Exosome Development and Manufacturing Services Market Comprehensive Size and Share Assessment 2026 to 2035 - openPR.com

openPR.com - Mar 31, 2026

Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication - BioInformant

BioInformant - Apr 06, 2024

Vicarious Surgical Hires Stephen From as CEO - Medical Product Outsourcing

Medical Product Outsourcing - Aug 04, 2025

Robotic surgery heats up with clearances and clinical trials - Modern Healthcare

Modern Healthcare - Aug 19, 2025

Research startup develops new stroke patient therapies - UGA Today

UGA Today - Feb 24, 2021

Aruna Bio’s Exosome AB126 Cleared for US Trial in Acute Ischemic Stroke - CGTLive®

CGTLive® - Jan 23, 2024

Aruna Bio secures US patent for exosome-derived neuroinflammation treatment - Healio

Healio - Aug 20, 2024

ARUNA BIO APPOINTS STEPHEN FROM AS CHIEF EXECUTIVE OFFICER - PR Newswire

PR Newswire - Apr 27, 2022

Aruna Bio Announces Issuance of a New Composition of Matter Patent Covering Neural Exosomes in Japan - BioInformant

BioInformant - Jun 24, 2022

Mary M. Worthington Obituary April 19, 2025 - McGuire & Davies Funeral Home and Crematory

McGuire & Davies Funeral Home and Crematory - Apr 19, 2025

Vicarious Surgical names Stephen From as next CEO - Yahoo Finance

Yahoo Finance - Aug 01, 2025

Exosome Therapeutics Are Paving a Path to Clinical Readiness - BioSpace

BioSpace - Mar 04, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment